{
  "docId": "019dd923-5fed-74f2-a96f-364382cb2b75",
  "docSlug": "bi-dc35af3bd0eea4cf",
  "documentTitle": "HMNC Brain Health pitch deck: $14 million for precision treatments",
  "authorId": "Pitchdecks",
  "authorName": "HMNC Brain Health",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 8,
  "pageCount": 12,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide uses a dual-track timeline (Rx and CDx) for each program.",
  "elementsJson": [
    "data_table",
    "timeline_visual"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fed-74f2-a96f-364382cb2b75/8",
  "deckHref": "/decks/019dd923-5fed-74f2-a96f-364382cb2b75",
  "deckJsonHref": "/decks/019dd923-5fed-74f2-a96f-364382cb2b75.json",
  "deckAnchorHref": "/decks/019dd923-5fed-74f2-a96f-364382cb2b75#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.38,
        "x": 0.58,
        "y": 0.35
      },
      "kind": "chart",
      "text": "Developmental progress bars for Rx and CDx",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7ceab016-beab-493d-8a34-fc098bb6c013",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.95,
        "x": 0.03,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "ABCB1, ATP Binding Cassette Subfamily B Member 1; CDx, companion diagnostic; CRHR1, corticotropin releasing hormone receptor 1; KET-01, oral prolonged release formulation of ketamine; MDD, major depressive disorder; MOA, mechanism of action; NDA, new drug application; NMDAR, N-methyl-D-aspartate receptor; PMA, premarket approval; PTSD, post-traumatic stress disorder; Rx, prescription medicine; TRD, treatment-resistant depression; V1bR, vasopressin V1b receptor.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b65a9753-beef-447d-8992-5e6d9b325570",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.95,
        "x": 0.03,
        "y": 0.2
      },
      "kind": "table",
      "text": "Program, Indication, MOA, Companion Diagnostic, Estimated Market Approval, Developmental Stage",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2f0b5b33-e4ac-4073-8e41-2258d2be4afa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.5,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "CO-DEVELOPMENT PIPELINE OF ANTIDEPRESSANTS AND COMPANION DIAGNOSTICS",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3986b0ee-56a9-41d7-8066-0c927f7f4bd0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "26939c96-710e-48ce-9de6-a454624bfda2",
      "evidence": "Pipeline timeline visualization",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 10,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "723e4b79-0471-4e54-9684-ccd3140a0b94",
      "evidence": "Problem statement and traction",
      "position": 0,
      "objective": "Highlighting the cost of not adopting precision psychiatry",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 10,
      "from": 8,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "77608a65-a053-4cbb-bd44-0999621d3ce8",
      "evidence": "Co-development pipeline and traction",
      "position": 1,
      "objective": "Explaining the timeliness of the investment opportunity",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.6,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}